'
4
1.

2.

3.

4.

5.

6.

7.
Endocrine
Disruptor
Methods
Validation
Subcommittee
Resource
Book
July
23­
24,2002
Table
of
Contents
Cf
a.
General
Procedural
P%;

1.2
March
25­
27
2002
EDMVS
Final
Meeting
Summary
1.3
EDMVS
Work
Plan,
revised
1.4
Criteria
 or
Screens
Presentation
­
Review
the
EDSTAC
Recommendations
1.1
Proposed
Agenda
,
F
*,.

i,,$,+,?.
e:
4'

pi4
.**;'
B:
:%
,
~
y
:,"'>
,
.
&
9
,
,.
,+
5
rr,.:
"+

s:­:
+$'

p
p
r;>
zit;
$""!
e.':
T?
u1
CT;
Pubertals
­
Special
Study:
Restricted
Feeding
(
Tier
I)
2.1
(
Report
will
be
made
available
upon
finalization)
2.2
Pubertals
­
Special
Study:
Restricted
Feeding
Questions
ICCVAM­
NICEATM
­
In
Vitro
EIUAR
Assays
3.1
Estrogen
Receptor
Binding
Assays
­
Executive
Summary
3.2
Androgen
Receptor
Binding
Assays
­
Executive
Summary
3.3
Estrogen
Receptor
Transcriptional
Activation
Assays
­
Executive
3.4
Androgen
Receptor
Transcriptional
Activation
Assays
­
Executive
summary
summary
General
Dose
Setting
Issues
4.1
Dose
Setting
Discussion
Paper
4.2
General
Dose
Setting
Questions
Mammalian
2­
Generation
­
PTU
Special
Study
(
Tier
11)
5.1
Mammalian
2­
Generation
­
PTU
Special
Study
Report
5.2
Mammalian
2­
Generation
­
PTU
Special
Study
Questions
Amphibian
Metamorphosis
Detailed
Review
Paper
(
Tier
I)
6.1
Amphibian
Metamorphosis
Detailed
Review
Paper
6.2
Amphibian
Metamorphosis
Questions
Invertebrate
Detailed
Review
Paper
(
Tier
11)
7.1
Invertebrate
Detailed
Review
Paper
7.2
Invertebrate
Questions
.
le­

i
